Clinstile brings together a group of health professionals, selected, trained and committed, guided by a Code of Ethics as well as equipped with modern technologies for conducting clinical studies that meet national and international standards.
The Clinical Research Site began operations in September 2011 for the purpose of conducting clinical trials sponsored by the pharmaceutical industry to help new drugs reach patients
To date more than 60 Phase 2 and 3 clinical trials have been successfully completed and in several of them Clinstile was a top recruiter at national and global levels. Due to its high performance Clinstile has successfully completed audits from CRO, sponsor and MoH.
Clinstile has positioned itself as a quality clinical research site, seeking to meet and exceed the recruitment projections with proactive strategies, keeping up-to-date SOPs for all the procedures performed, ensuring fast and flexible processes for the implementation of clinical trials.
To perform Phase 2, 3 and 4 clinical trials for the pharmaceutical industry in many therapeutic areas, such as: urology, rheumatology, neurology, nephrology, endocrinology, cardiology, pulmonology, oncology, gastroenterology under strict quality and ethical standards, always seeking the welfare of our patients and the satisfaction of our clients.
To be a leading research site for the therapeutic areas provided.
Quality, Ethics, Responsibility, Honesty, Team work, Community.